Serial Number | 79420206 |
Word Mark | CHO.SET PROMOTER LIBRARY |
Filing Date | Thursday, December 19, 2024 |
Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
Status Date | Tuesday, June 10, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Biopharmaceuticals; synthetic promoters; protein synthesis inhibitors; human plasma protein; blood protein fractions; endogenous antigens; exogenous antigens; DNA synthesis inhibitors; antibodies; regulatory proteins for medical use; RNA synthesis inhibitors; mRNA vaccines; synthetic peptides for pharmaceutical purposes; antigens; mycolic acid synthesis inhibitors; preparations for detecting mutation in prion genes for medical purposes; viral antigens; hormone preparations; viral antigens; human plasma protein; protein synthesis inhibitors; viral vaccines; blood protein fractions; endogenous antigens; human vaccine preparations; AAV viral vector and recombinant protein; genetic vectors; chemical preparations for use in DNA analysis [medical]; therapeutic DNA and mRNA. |
Goods and Services | Collection of information, particularly commercial, scientific, health, gene and cell information; collection of data, particularly commercial, scientific, health, gene and cell data; computerized database management; computerized file management; management of files and records related to the health status of individuals, molecules and formulation for medical use, as well as medicines and medical research; data retrieval services; statistical information compilation services; data processing services; computer data processing; computer files and data in electronic format, hardware and products for medical and non-medical research and analysis; collating and maintaining computer files and data in electronic format, materials and products for medical and non-medical research and analysis; the bringing together, for third parties, of service offers relating to capture, collection, analysis, processing and use of data, particularly medical, health gene and cell research data; data capture, collection, analysis, processing and use of data, particularly health, gene and cell data; information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field; compilation of scientific and technical information; compilation of information related to people's health, to medicines [medical information] and to gene and cell therapy; compilation of medical reports, medical prescriptions and recommendations [medical information]; information and advice concerning all the aforesaid services. |
Goods and Services | Proteins for use in recombinant DNA technology [other than for medical use]; synthetic promoters; proteins for use in recombinant DNA technology [other than for medical use]; enzymes [other than for medical use] for use in the continuous homogenous isothermal amplifications of specific DNA templates; enzymes [other than for medical use] for detecting protein fractions; proteins for binding antibodies [other than for medical use]; chemical preparations for use in DNA analysis [other than medical]; enzymes [other than for medical use] in detecting proteins; enzymes [other than for medical use] for use in the continuous homogenous isothermal amplifications of specific MA templates; nucleic acid sequencing programs [other than for medical use]; enzymes [other than for medical use] for labelling protein fractions; nucleic recombinant acids; enzymes [other than for medical use] for measuring proteins. |
Goods and Services | Medical analysis for diagnosis and treatment of persons; medical, gene and cell data analysis; conducting of studies and analyses on health of persons, medicines for medical diagnostic and treatment purposes and for gene and cell therapy; medical screening; preparation of medical reports and medical recommendations; carrying out disease diagnostics; advisory services in the field of health care, gene and cell therapy; medical diagnosis services; stem cell therapy services; stem cell storage; stem cell bank services; cultured cell bank services for medical transplantation; medical treatment using cultured cells; RNA or DNA analysis for cancer diagnosis and prognosis; medical services relating to the removal, treatment and processing of human genes and cells; information and advice concerning all the aforesaid services. |
Goods and Services | Structural and functional analysis of genomes; genetic fingerprinting; genetic research; research in the field of gene therapy; laboratory research in the field of gene expression; analysis in the field of molecular biology; biochemical analysis; structural and functional analysis of genomes; research and development services in the field of gene expression systems; research and development services in the field of genes and cells; biotechnology research; scientific research in the field of genetics and genetic engineering; biological analysis; genetic mapping for scientific purposes; genetic engineering services; biotechnology testing; biochemical research and development; scientific and technical analysis and research; computer testing and analysis; quality control and auditing; quality control of software, scientific and technical data and scientific and technical analyses; design of technical and scientific studies; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and software, particularly for artificial intelligence and decision support systems; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and computer software and platforms for consulting, analyzing, exchanging and sharing data, particularly in a collaborative work environment; design, development, formulation, updating and testing of new medicines and new medicine formulas [scientific research]; evaluation of the performance of medical treatments [quality control]; design, development, selection, training and remote provision [SaaS] of models and software for gene and cell therapy; software as a service [SaaS]; platforms for gene and cell therapy research as SaaS [Software as a Service]; software as a service [SaaS] for data input, extraction, processing, display and storage relating to gene and cell therapy; provision of information relating to scientific technology; provision of temporary use of non-downloadable software for data processing and analysis relating to gene and cell therapy; preparation of technical and scientific manuals; preparation of technical and scientific reports; technology research; scientific research services; data analysis computer services; computer programming services for data analysis and interpretation relating to gene and cell therapy; information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field; research in the field of gene therapy; stem cell research services; stem cell research; advisory services relating to gene therapy research; research and development services in the field of gene expression systems; cell separation technology services; cell separation research services; laboratory research in the field of gene expression; biotechnology research for determining the neuronal survival of molecules in animal models; biological cloning services; research and development of vaccines and medicines; advisory services relating to gene therapy research; laboratory services relating to the production of monoclonal antibodies; biotechnology research; research in the field of cell therapy. |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 27, 2025 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 27, 2025 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 27, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 27, 2025 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 27, 2025 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SYNGENSYS LIMITED |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | GB |
Event Date | Event Description |
Thursday, March 27, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, March 28, 2025 | APPLICATION FILING RECEIPT MAILED |
Thursday, June 5, 2025 | ASSIGNED TO EXAMINER |
Friday, March 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, June 10, 2025 | NON-FINAL ACTION WRITTEN |
Wednesday, June 11, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |